• Trial Status
  • Patients randomised:
  • 4662

Brief Summary

This 5 year multicentre large randomised trial is designed to answer two clinically important questions:

  1. Should low-dose aspirin be continued up until the day of CABG surgery?
  2. Should tranexamic acid be used for all at-risk CABG surgery?

The trial commenced enrolment in April 2006.

Main Study Hypothesis

In patients undergoing elective coronary artery surgery and at increased risk of complications, aspirin and/or tranexamic acid will reduce the incidence of mortality or major morbidity when compared with those not receiving such therapy.

Funding:

Australian NHMRC Project Grant (ID 334015)



Registration:

ACTRN No. ACTRN012605000557639

For further information contact

Sophie Wallace

or click Register your interest